Search for: "Johnson v. GlaxoSmithKline, Inc." Results 1 - 20 of 32
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2024, 10:55 am by Evangelina Cantu
Since 2019, the following pharmaceutical manufacturers have posted seven or more notices of correction: Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Novo Nordisk, and Purdue Pharmaceuticals. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Civil Procdedure – Final Judgment: Johnson & Johnson Vision Care, Inc. v. [read post]
3 Sep 2015, 6:36 am
”).As to deference, Defendants cite a non-binding case, Schering-Plough Healthcare Prods., Inc. v. [read post]
10 Apr 2012, 5:00 am by Kimberly A. Kralowec
GlaxoSmithKline, Inc. (2008) 166 Cal.App.4th 1497, 1510-1513 & fn. 8 (Johnson) [assuming the point while expressing reservations].) [read post]
26 Jan 2012, 5:01 pm by The Complex Litigator
GlaxoSmithKline, Inc. (2008) 166 Cal.App.4th 1497, 1510-1513 & fn. 8 (Johnson) [assuming the point while expressing reservations].) [read post]
18 Jan 2012, 1:40 pm by Matt C. Bailey
GlaxoSmithKline, Inc. (2008) 166 Cal.App.4th 1497, 1510-1513 & fn. 8 (Johnson) [assuming the point while expressing reservations].) [read post]
1 Oct 2009, 2:14 am
GlaxoSmithKline PLC, 2008 WL 2247067 (E.D. [read post]